Academic literature on the topic 'Photodynamic treatment'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Photodynamic treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Photodynamic treatment"

1

Poljacki, Mirjana, Marina Jovanovic, Ljubinka Matovic, Branislava Lugonja, Branislava Gajic, and Tatjana Ros. "Topical photodynamic therapy." Archive of Oncology 14, no. 1-2 (2006): 39–44. http://dx.doi.org/10.2298/aoo0602039p.

Full text
Abstract:
Topical photodynamic therapy is a therapeutic modality in development, thus arises grate interest among dermatologists worldwide. It is an effective therapy for actinic keratosis, superficial BCC and Bowenos disease. Treatment efficacy, good cosmetics, low risk of skin cancer, low invasiveness, low rate of adverse events, facility for treating multiple or large lesions, especially in poor healing sites and, for penile, digital and facial involvement, low general toxicity and possibility of repeating the treatments with the same efficiency, enable topical photodynamic therapy to become increasingly practiced treatment modality. Researching aimed topical photodynamic therapy to prove as a treatment modality for clinical use in other dermatoses, is in experimental phase. To answer the question when dermatologist should consider using topical photodynamic therapy treatment modatility, we are present available date.
APA, Harvard, Vancouver, ISO, and other styles
2

Sazhnev, Dmitrii Igorevich, Alexandr Alexeevich Andreev, and Alexandr Anatol'evich Glukhov. "Photodynamic therapy." Journal of Experimental and Clinical Surgery 12, no. 2 (March 29, 2019): 141–46. http://dx.doi.org/10.18499/2070-478x-2019-12-2-141-146.

Full text
Abstract:
The article presents data on the high-tech method of treatment-photodynamic therapy (PDT). An overview of the history of the use of photochemical reaction in the treatment of patients is given. The mechanisms of therapeutic action of PDT, the advantages of the method in comparison with other methods of antimicrobial action are described in detail; the indications and contraindications for this method of treatment are given. The article lists used for PDT photosensitizers of different generations and laser devices capable of emitting laser radiation of the required wavelength. The overview contains information about the efficiency of the method of PDT with certain diseases. Based on the literature review, it is concluded that PDT is a modern and promising method of treatment that can significantly improve the quality of care for patients with various diseases, which are based on cell proliferation. The proven effectiveness of the method of photodynamic therapy and its advantage over other antimicrobial treatments demonstrate the relevance of its wider introduction into clinical practice.
APA, Harvard, Vancouver, ISO, and other styles
3

Manyak, M. J., A. Russo, P. D. Smith, and E. Glatstein. "Photodynamic therapy." Journal of Clinical Oncology 6, no. 2 (February 1988): 380–91. http://dx.doi.org/10.1200/jco.1988.6.2.380.

Full text
Abstract:
Photodynamic therapy (PDT) is an experimental cancer treatment modality that selectively destroys cancer cells by an interaction between absorbed light and a retained photosensitizing agent. This review discusses the basic components of photodynamic activity and examines the clinical applications of photodynamic therapy in cancer treatment. Treatment of superficial and early-stage malignancies is encouraging. Technologic advancement and further elucidation of the fundamental basis of photodynamic action should permit treatment of more advanced malignancies.
APA, Harvard, Vancouver, ISO, and other styles
4

Huang, Zheng. "A Review of Progress in Clinical Photodynamic Therapy." Technology in Cancer Research & Treatment 4, no. 3 (June 2005): 283–93. http://dx.doi.org/10.1177/153303460500400308.

Full text
Abstract:
Photodynamic therapy (PDT) has received increased attention since the regulatory approvals have been granted to several photosensitizing drugs and light applicators worldwide. Much progress has been seen in basic sciences and clinical photodynamics in recent years. This review will focus on new developments of clinical investigation and discuss the usefulness of various forms of PDT techniques for curative or palliative treatment of malignant and non-malignant diseases.
APA, Harvard, Vancouver, ISO, and other styles
5

Hasan Zeynalova, Jala, Gulnara Salam Mammedova, Gunel Mammad Sultanova, İrada Arif Mammedxanova, Sevda Tariyel Huseynova, and Shahla Rafael Yusubova. "TREATMENT OF ORAL LICHEN PLANUS LICHEN PLANUS WITH PHOTODYNAMIC THERAPY." NATURE AND SCIENCE 14, no. 09 (November 23, 2021): 10–13. http://dx.doi.org/10.36719/2707-1146/14/10-13.

Full text
Abstract:
Ağız boşluğunda yastı dəmirovun meydana gəlməsi ilə bağlı irəli sürülən bir sıra nəzəriyyələrə baxmayaraq, bu növ allergiya polietioloji hesab olunur.Ağız boşluğunun qırmızı yastı dəmirovu bir insandan digərinə keçə bilməz. Xəstəlik immun sisteminin naməlum səbəblərdən ağızın selikli qişasında hüceyrələrin strukturunun pozulması nəticəsində baş verir. Simptomlar adətən müalicə olunur, lakin ağızda qırmızı yastı dəmirovu olan insanlar mütəmadi həkim konsultasiyasına ehtiyac duyurlar. Açar sözlər: ağız boşluğunun qırmızı yastı dəmirovu, fotodinamik terapiya, metilen abısı
APA, Harvard, Vancouver, ISO, and other styles
6

Giovannini, A., P. Neri, L. Mercanti, and C. Brue. "Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation." British Journal of Ophthalmology 91, no. 5 (January 3, 2007): 620–23. http://dx.doi.org/10.1136/bjo.2006.103135.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zhao, Tianyuan, Jungyul Song, Yuzhuo Ping, and Meihua Li. "The Application of Antimicrobial Photodynamic Therapy (aPDT) in the Treatment of Peri-Implantitis." Computational and Mathematical Methods in Medicine 2022 (May 12, 2022): 1–8. http://dx.doi.org/10.1155/2022/3547398.

Full text
Abstract:
Background. This literature review evaluates the mechanisms and efficacy of different types of antimicrobial photodynamic therapy (aPDT) for treating peri-implantitis by reviewing existing experimental studies to provide guidance for the clinical application of antibacterial photodynamic therapy (aPDT) in oral implants. Materials and Methods. From February 2001 to February 2021, we have collected 152 randomized controlled trials of aPDT for peri-implantitis by searching the experimental studies and clinical trials published in PubMed, Embase, Web of Science, and Google Scholar databases via online search. After screening the retrieved literature, we finally selected 10 statistically significant literature for evaluation and review. Results. Compared with the traditional nonsurgical treatment of peri-implantitis, the aPDT was superior to the traditional mechanical irrigation treatment group in terms of periodontal indexes PD, BOP, PLI, and postoperative effect, and the difference was statistically significant ( P < 0.05 ). Furthermore, the combination of the aPDT and other treatments shows the synergistic antibacterial effect, signifying better clinical effect in many aspects ( P < 0.05 ). In these 10 papers, by comparing the probe depth (PD), bleeding on probing (BOP), synosteosis, and periodontal pathogenic bacteria detection, etc., obtained after treating peri-implantitis by application of the antimicrobial photodynamic therapy, and using the SPSS data analysis software for statistical data processing, we found that the antimicrobial photodynamic therapy combined with other periodontal treatments has a more prominent postoperative effect. Meanwhile, the antibacterial photodynamic therapy with targeted action of photosensitizer has strong specificity to some bacteria, while the synthetic photosensitize for antibacterial photodynamic therapy can show good inactivation effect on broad-spectrum periodontal anaerobes without side effect. Conclusion. The experimental studies and clinical data of antibacterial photodynamic therapy for treating peri-implantitis show a good postoperative treatment effect. In addition, it did not develop resistance due to the use of antibiotic drugs. Owing to multiple advantages from combining antibacterial photodynamic therapy and other treatments, it is applicable for clinical treatment.
APA, Harvard, Vancouver, ISO, and other styles
8

Warloe, Trond, and Sigrid I. Kvaal. "Photodynamic Treatment of Oral Lesions." Journal of Environmental Pathology, Toxicology and Oncology 26, no. 2 (2007): 127–33. http://dx.doi.org/10.1615/jenvironpatholtoxicoloncol.v26.i2.70.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gümüs, Pinar, and Nurcan Buduneli. "Photodynamic Therapy and Periodontal Treatment." Clinical Anti-Inflammatory & Anti-Allergy Drugs 2, no. 1 (May 17, 2016): 38–42. http://dx.doi.org/10.2174/221270380201160517190017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

ÖZCAN, Erkan. "Periodontitis and Photodynamic Treatment: Review." Turkiye Klinikleri Journal of Dental Sciences 21, no. 3 (2015): 229–34. http://dx.doi.org/10.5336/dentalsci.2011-25591.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Photodynamic treatment"

1

Hopper, Colin. "Photodynamic therapy for the treatment of oral cancer." Thesis, University College London (University of London), 2006. http://discovery.ucl.ac.uk/1444444/.

Full text
Abstract:
Photodynamic therapy (PDT) describes an interaction of a drug, light and oxygen that results in cell killing. The aim of this thesis is to describe the potential clinical applications of the three most commonly used drugs in PDT - aminolaevulinic acid (ALA), Photofrin and Foscan . Before it was considered safe to use this therapy on patients, a series of preclinical studies were undertaken to establish the safety of the treatment and to try to understand the likely clinical effects on normal tissues. Following this, a series of studies was undertaken to look at the biological effect of PDT on normal and neoplastic tissue. These studies showed the treatment to be safe and effective in destroying tissue while allowing healing with preservation of sufficient tissue structure to maintain tissue contour and function. Next, clinical studies were undertaken on dysplasia, early oral cancer and field change disease using the 3 sensitisers. ALA was found to be useful in the treatment of dysplasia, but has a very superficial effect so is not indicated for treatment of invasive disease. Photofrin and Foscan have a much deeper effect and can be used to treat early cancer and superficial field change disease. Both drugs have problems of prolonged sensitivity to light varying from 2 weeks (Foscan ) to 3 months (Photofrin ). Treatment times also vary from 200s (Foscan ) to 1000s (Photofrin ). The depth of effect limits the use of surface illumination to a maximum of 1cm, however, the use of interstitial therapy, where the light is delivered directly into a neoplastic tissue target allows more advanced cancers to be treated. Currently, Foscan is the only drug licensed for head and neck cancer and then only in the advanced or palliative setting where all other options have been exhausted or are not appropriate. While there is no single drug or technique for the treatment of all stages of oral cancer, PDT is now beginning to be used alongside surgery, radiotherapy and chemotherapy.
APA, Harvard, Vancouver, ISO, and other styles
2

Alsaif, Aysha S. Y. A. S. "Treatment of dental plaque biofilms using photodynamic therapy." Thesis, University of Leeds, 2017. http://etheses.whiterose.ac.uk/18523/.

Full text
Abstract:
BACKGROUND: Photodynamic therapy (PDT) is a treatment modality involving a dye that is activated by exposure to light of a specific wavelength in the presence of oxygen to form oxygen species causing localised damage to microorganisms. AIM: To determine the most effective bactericidal incubation and irradiation times of erythrosine-based PDT, using a tungsten filament lamp, on in vivo- formed dental plaque biofilms. MATERIALS AND METHODS: The study was a two-phase randomised controlled study consisting of in-vitro and in-situ phases. Phase-1 aimed to determine the most appropriate incubation-time using erythrosine(220μM) based-PDT on lactobacillus species grown in-vitro. Phase-2 was conducted on 18-healthy adult participants wearing intraoral appliances with human enamel slabs to collect dental plaque samples in two separate periods for use in arm-1 and arm-2. For phase-2, accumulated dental plaque samples were tested under different experimental conditions; a) Control-1 (No erythrosine, no light); b) Control-2 (+Erythrosine, no light); c) Treatment-1 (+Erythrosine, +15min continuous light); d) Treatment-2 (+Erythrosine, +30sec light pulses for 5- times separated by 1min dark periods). Incubation-times of 15min and 2min were used in arm-1 and arm-2, respectively; as adapted from the previous pilot study and phase-1. Following treatment, percentage reduction of total bacterial counts were compared between the different groups. Additionally, Confocal Laser Scanning Microscopy(CLSM) was used to investigate the effect of PDT on in vivo-formed plaque biofilms. RESULTS: Significant reductions in the percentage of total bacterial counts (~93-95%) of in vivo-formed biofilms were found when using either 2min or 15min incubation-times and applying 15min continuous light. Whereas, when applying fractionated light, there was more cell death when 15min incubation-time was used (~91%) compared with the 2min incubation-time (~64%). CLSM results supported these findings. CONCLUSION: Improving the clinical usefulness of PDT by reducing its overall treatment time seems to be promising and effective in killing in vivo- formed dental plaque biofilms.
APA, Harvard, Vancouver, ISO, and other styles
3

Dronyk, I. I. "Photodynamic therapy in complex treatment of generalized periodontitis." Thesis, БДМУ, 2021. http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/19118.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stritt, Andrea Christina. "Photodynamic therapy in the treatment of actinic keratosis /." Bern : [s.n.], 2008. http://www.ub.unibe.ch/content/bibliotheken_sammlungen/sondersammlungen/dissen_bestellformular/index_ger.html.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Millson, Charles Edward. "Photodynamic therapy for the treatment of helicobacter pylori infection." Thesis, King's College London (University of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.281686.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pereira, José Carlos Ribeiro Ferreira. "Cytoskeleton regulation in bladder cancer cells after photodynamic treatment." Master's thesis, Universidade de Aveiro, 2016. http://hdl.handle.net/10773/21089.

Full text
Abstract:
Mestrado em Biologia Molecular e Celular
A terapia fotodinâmica (PDT) é uma modalidade promissora para o tratamento do cancro. Esta terapia baseia-se na interação entre um composto químico (fotossensibilizador, PS), luz com um determinado comprimento de onda e oxigénio molecular para originar a produção de espécies reativas de oxigénio (ROS). Devido à sua elevada reatividade, estas espécies tóxicas podem causar danos severos conduzindo à morte celular. Atualmente, os PS disponíveis na clínica para o tratamento de tumores apresentam baixa seletividade para as células tumorais. Estudos anteriores do nosso grupo descreveram uma porfirina conjugada com unidades dendríticas de galactose (PorGal8) como um novo PS solúvel em solução aquosa, capaz de gerar ROS após fotoativação e com reconhecimento por parte de proteínas (galectina-1) que se encontram sobreexpressas nas células do cancro da bexiga. Vários estudos têm descrito alterações no citoesqueleto em resposta ao tratamento fotodinâmico. No entanto, a contribuição da desorganização do citoesqueleto na morte celular induzida por PDT encontra-se pouco esclarecida. Neste trabalho, avaliámos de que forma alterações nos constituintes do citoesqueleto – filamentos de actina, filamentos intermédios e microtúbulos – estão relacionadas com morte celular induzida por PDT com PorGal8. O uptake de PorGal8 em duas linhas celulares do cancro da bexiga derivadas de carcinoma de células transicionais (UM-UC-3 e HT-1376), foi dependente da concentração. O uptake celular de PorGal8 foi superior nas células UM-UC-3, que exibem níveis superiores da proteína galectina-1, comparativamente com as células HT-1376. PorGal8 mostrou não ser tóxico no escuro. A fotoativação da PorGal8 resultou numa fototoxicidade significativamente superior nas células UM-UC-3 relativamente às células HT-1376. A PorGal8 não induziu alterações significativas nos níveis de proteína α-tubulina nas células UM-UC-3. No entanto, observou-se uma redução significativa nos níveis de α-tubulina nas células HT-1376 vinte e quatro horas após tratamento com irradiação. Apesar de se ter observado uma recuperação na organização dos microtúbulos em algumas células, a intensidade da fluorescência diminuiu consideravelmente na maior parte das células HT-1376. Uma redução significativa nos níveis de proteína dos filamentos intermédios (vimentina) foi observada em ambas as linhas celulares vinte e quatro horas após irradiação. Trinta minutos após a irradiação, as células UM-UC-3 e HT-1376 apresentaram uma clara retração nos filamentos de actina com perda de fibras de stress. Ao contrário das células UM-UC-3 em que não se verificaram sinais de recuperação, em algumas células HT-1376 verificou-se uma certa reorganização dos filamentos de actina, com curtas fibras de stress, longas extensões, grandes filopodia, o que parece sugerir uma possível recuperação das células HT-1376. A RhoA, uma proteína da família de pequenas proteínas GTPases, descrita como estando relacionada com a expressão da galectina-1, foi adicionalmente avaliada. Resultados preliminares indicaram que a PorGal8 induziu uma tendência para aumentar os níveis de RhoA nas células HT-1376 vinte e quatro horas após tratamento com irradiação. Concluindo, os nossos resultados contribuem para o esclarecimento dos mecanismos subjacentes dos efeitos fototóxicos da PorGal8. Uma melhor compreensão dos intervenientes e das alterações induzidas imediatamente após PDT nas estruturas do citoesqueleto em cancros resistentes à terapia, poderão contribuir para o desenvolvimento de novos agentes terapêuticos adjuvantes à PDT.
Photodynamic therapy (PDT) is a promising modality for the treatment of cancer that involves light of an appropriate wavelength and a photosensitizing drug (photosensitizer, PS), used in conjunction with molecular oxygen, leading to the production of reactive oxygen species (ROS). In a biological environment, these toxic species can interact with the cellular constituents eliciting cell death. Currently, the PS available show poor tumor specificity. Previous work from our research group reported a porphyrin conjugated with dendritic units of galactose (PorGal8) as a new water soluble PS, able to generate ROS after photoactivation and exhibiting increased selectivity to bladder cancer cells overexpressing galectin-1. Several studies reported cytoskeleton alterations derived from photodynamic treatments. However, the role of cytoskeleton disorganization in cell death induced by PDT remains unclear. In this work we evaluated whether changes in the cytoskeletal constituents - actin filaments, intermediate filaments and microtubules - are correlated with cell death triggered by PDT with PorGal8. The uptake of PorGal8 in two bladder cancer lines derived from transitional cell carcinoma (UM-UC-3 and HT-1376 cells), was concentration dependent. Cellular uptake of PorGal8 was higher in UM-UC-3 cells that express higher levels of galectin-1 protein than HT-1376 cells. PorGal8 was nontoxic in dark. Photoactivation of PorGal8 resulted in a significantly higher phototoxicity in UM-UC-3 cells than HT-1376 cells. PorGal8 did not change the α-tubulin protein levels in UM-UC-3 cells but reduced α-tubulin twenty-four hours after photodynamic activation in HT-1376 cells. Although a few cells showed a recovery in microtubules organization, the fluorescence intensity decreased noticeably in most of the HT-1376 cells. A significant decrease in intermediate filaments (vimentin) protein levels was exhibited in both cell lines twenty-hours after irradiation. Thirty minutes post-irradiation, UM-UC-3 and HT-1376 cells showed a clear retraction of actin filaments with loss of stress fibers. Although no recovery was observed in UM-UC-3 cells, some cells present some reorganization in actin filaments, presenting short stress fibers, long extensions, like large filopodia, suggesting a possible recovery in HT-1376 cells. A small GTPases family protein, RhoA, referred to be involved with galectin-1 expression, was also evaluated, with preliminary results indicating a tendency towards an increase in HT-1376 cells twenty-four hours after therapy. Overall, our results give new insights into the mechanisms underlying the phototoxic effects of PorGal8. Better understanding the intrinsic web of events and alterations on cytoskeleton structures induced immediately after photodynamic treatment in resistant cancers may contribute to envisage new potential therapeutic adjuvants for PDT.
APA, Harvard, Vancouver, ISO, and other styles
7

Mitzel, Frieder. "Synthesis of acetylenic phthalocyanine analogues as sensitisers for photodynamic therapy." Thesis, University College London (University of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249357.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rogowska, Agnieska Zofia. "Photodynamic therapy for the treatment of cancer of the pancreas." Thesis, University College London (University of London), 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.394933.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Thissen, Monique Rosalie Thérèse Mathieu. "Treatment of basal cell carcinoma in the light of photodynamic therapy." [Maastricht : Maastricht : Universiteit Maastricht] ; University Library, Maastricht University [Host], 2000. http://arno.unimaas.nl/show.cgi?fid=5962.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Fielding, David Ivor Keith. "Effects of interstitial laser photoagulation and photodynamic therapy on lung parenchyma." Thesis, University College London (University of London), 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.264699.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Photodynamic treatment"

1

service), SpringerLink (Online, ed. Photodynamic Therapy in Dermatology. New York, NY: Springer Science+Business Media, LLC, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kessel, David. Optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy XIX : 23-25 January 2010, San Francisco, California, United States. Edited by SPIE (Society). Bellingham, Wash: SPIE, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kessel, David. Optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy XVIII : 24-25 January 2009, San Jose, California, United States. Edited by SPIE (Society). Bellingham, Wash: SPIE, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Calif.) Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy (Conference) (22nd 2013 San Francisco. Optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy XXII, 2-4 February 2013 San Francisco, California, United States. Edited by Kessel David editor, Hasan Tayyaba editor, SPIE (Society), and SPIE Photonics West (Conference) (2013 : San Francisco, Calif.). Bellingham, Washington: sponsored and published by SPIE, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kessel, David, and Tayyaba Hasan. Optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy XXI : 21-22 January 2012, San Francisco, California, United States. Edited by SPIE (Society). Bellingham, Wash: SPIE, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

(Society), SPIE, ed. Optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy XX : 22-23 January 2011, San Francisco, California, United States. Bellingham, Wash: SPIE, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

name, No. Optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy XII : 25-26 and 28 January 2003, San Jose, California, USA. Bellingham, WA: SPIE, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gold, Michael H. Photodynamic Therapy in Dermatology. Springer New York, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Davies-Shawhyde, Nick. Metronomic photodynamic therapy as a treatment for malignant brain tumours. 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

F, Horrobin David, ed. New approaches to cancer treatment: Unsaturated lipids and photodynamic therapy. Edinburgh: Churchill Livingstone, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Photodynamic treatment"

1

DeLaney, T. F. "Photodynamic Therapy." In New Directions in Cancer Treatment, 93–116. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83405-9_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jemec, Gregor B. E. "Photodynamic Therapy." In Non-Surgical Treatment of Keratinocyte Skin Cancer, 133–35. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-79341-0_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Núñez, Tomás G., and Tamara Portas. "Application of Photodynamic Treatment." In Fluorescence Imaging for Surgeons, 279–84. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-15678-1_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fabris, Clara, Marina Soncin, Monica Camerin, Furio Corsi, Ilaria Cattin, Fabrizio Cardin, Laura Guidolin, Giulio Jori, and Olimpia Coppellotti. "Photodynamic Therapy: A Novel Promising Approach for the Treatment of Spontaneous Microbial Infections in Pet Animals." In Photodynamic Therapy, 255–67. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-39629-8_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ferreira-Strixino, Juliana, and Elodie Debefve. "Photodynamic therapy in cancer treatment." In Lasers in Dentistry, 346–50. Hoboken, NJ: John Wiley & Sons, Inc, 2015. http://dx.doi.org/10.1002/9781118987742.ch44.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gold, Michael H. "Photodynamic Therapy for the Treatment of Sebaceous Gland Hyperplasia." In Photodynamic Therapy in Dermatology, 47–51. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1298-5_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Akir, Surianti Binti Md, and Peter Foley. "Topical Methyl Aminolevulinate Photodynamic Therapy for the Treatment of Actinic Keratosis." In Photodynamic Therapy in Dermatology, 61–75. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1298-5_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gold, Michael H. "Photodynamic Therapy for the Treatment of Verrucae, Condylomata Acuminata, and Molluscum Contagiosum Lesions." In Photodynamic Therapy in Dermatology, 97–103. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1298-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Shokrollahi, Kayvan, and Charlotte Hardman. "Photodynamic Therapy for the Treatment of Scars." In Laser Management of Scars, 87–92. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-52919-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Agnihotry, Shikha, Mohammad Anas, Ajeet K. Srivastav, Deepti Chopra, Jaya Upadhayay, and Syed Faiz Mujtaba. "Role of Photodynamic Therapy in Cancer Treatment." In Photocarcinogenesis & Photoprotection, 159–77. Singapore: Springer Singapore, 2018. http://dx.doi.org/10.1007/978-981-10-5493-8_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Photodynamic treatment"

1

Chang, Kwang Poo, Bala K. Kolli, Dennis K. P. Ng, Laura Manna, Robert L. Elliott, Raffaele Corso, X. P. Jiang, et al. "Progress toward development of photodynamic vaccination against infectious/malignant diseases and photodynamic mosquitocides." In Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases, edited by Tianhong Dai. SPIE, 2018. http://dx.doi.org/10.1117/12.2281437.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Brovko, Lubov, Nadya A. Romanova, Christina Leslie, Helene Ollivier, and Mansel W. Griffiths. "Photodynamic treatment for surface sanitation." In Photonics North 2005, edited by Warren C. W. Chan, Kui Yu, Ulrich J. Krull, Richard I. Hornsey, Brian C. Wilson, and Robert A. Weersink. SPIE, 2005. http://dx.doi.org/10.1117/12.628596.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Avetisov, Sergey E., Maria V. Budzinskaja, Tatyana N. Kiseleva, Natalia V. Balatskaya, Irina V. Gurova, Victor B. Loschenov, Sergey A. Shevchik, Sergey G. Kuzmin, and Georgy N. Vorozhtsov. "Photodynamic Therapy for Treatment Subretinal Neovascularization." In European Conference on Biomedical Optics. Washington, D.C.: OSA, 2007. http://dx.doi.org/10.1364/ecbo.2007.6632_63.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lynch, David H., Sandra Haddad, Chistooher J. Jolles, Vernon J. King, Mark J. Ott, Bekkie Robertson, and Richard C. Straight. "Immunologic Effects Of Peritoneal Photodynamic Treatment." In OE/LASE '89, edited by Thomas J. Dougherty. SPIE, 1989. http://dx.doi.org/10.1117/12.978004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Avetisov, Sergey E., Maria V. Budzinskaja, Tatyana N. Kiseleva, Natalia V. Balatskaya, Irina V. Gurova, Viktor B. Loschenov, Sergey A. Shevchik, Sergey G. Kuzmin, and Georgy N. Vorozhtsov. "Photodynamic therapy for treatment subretinal neovascularization." In European Conference on Biomedical Optics, edited by Alfred Vogel. SPIE, 2007. http://dx.doi.org/10.1117/12.730392.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Oleinick, Nancy L., Munna L. Agarwal, Antonio R. Antunez, Marian E. Clay, Helen H. Evans, Ella Jo Harvey, Ronald M. Rerko, and Liang-yan Xue. "Effects of photodynamic treatment on DNA." In Optics, Electro-Optics, and Laser Applications in Science and Engineering, edited by Steven L. Jacques. SPIE, 1991. http://dx.doi.org/10.1117/12.44125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dimmer, Jesica Ayelen, Camila Ramos Silva, Susana Carolina Nunez Montoya, Jose Luis Cabrera, and Martha S. Ribeiro. "Photodynamic activity of natural anthraquinones on fibroblasts." In Photonic Diagnosis and Treatment of Infections and Inflammatory Diseases, edited by Tianhong Dai. SPIE, 2018. http://dx.doi.org/10.1117/12.2290666.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hendrich, Christian, Heyke C. Diddens, Hany R. Nosir, and Werner E. Siebert. "Treatment of rheumatoid arthritis using photodynamic therapy." In Fifth International Photodynamic Association Biennial Meeting, edited by Denis A. Cortese. SPIE, 1994. http://dx.doi.org/10.1117/12.203423.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ruiz, Alberto J., Ethan Philip M. LaRochelle, M. Shane Chapman, and Brian W. Pogue. "Low-cost smartphone-based dosimeter for individualization of PDT treatment planning for protoporphyrin IX based skin cancer treatment (Conference Presentation)." In 17th International Photodynamic Association World Congress, edited by Tayyaba Hasan. SPIE, 2019. http://dx.doi.org/10.1117/12.2528176.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nishimura, Takahiro, and Kunio Awazu. "Fluorescence imaging of photosensitizers in biological tissues for photodynamic diagnosis during interstitial photodynamic therapy." In Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXVIII, edited by David H. Kessel and Tayyaba Hasan. SPIE, 2019. http://dx.doi.org/10.1117/12.2508155.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Photodynamic treatment"

1

Akens, Margarete K., and Cari M. Whyne. Photodynamic Therapy Treatment to Enhance Fracture Healing. Fort Belvoir, VA: Defense Technical Information Center, June 2013. http://dx.doi.org/10.21236/ada611585.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Akens, Margarete K., Cari M. Whyne, Brian C. Wilson, Albert J. Yee, and Diane Nam. Photodynamic Therapy Treatment to Enhance Fracture Healing. Fort Belvoir, VA: Defense Technical Information Center, October 2012. http://dx.doi.org/10.21236/ada578788.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Alarcón, Marco, Tatiana Amagua, Donald Morales, and Ana Lucia Seminario. EFFECT OF PERIODONTAL TREATMENT IN HIV+ PATIENS: A SYSTEMATIC REVIEW. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2023. http://dx.doi.org/10.37766/inplasy2023.1.0032.

Full text
Abstract:
Review question / Objective: The objective of our study is to evaluate whether periodontal treatment influences clinical outcomes and immunological conditions in HIV+ patients. (P) Participants: VIH+ patients. (I) Interventions: Surgical treatment, photodynamic therapy, antimicrobials, others. (C) Comparison: Non-surgical treatment. (O) Outcome measures: - Periodontal outcomes: plaque scores, bleeding on probing, periodontal pocket Depth, clinical attachment levels; - VIH outcomes: -Count CD4+; -Microbiological analysis. Condition being studied: Our study will analyze the effect of periodontal treatment in HIV+ patients and will evaluate changes in periodontal, immunological and microbiological parameters.
APA, Harvard, Vancouver, ISO, and other styles
4

Oliveira, Analú, Túlio Ferrisse, Fernanda Basso, Carla Fontana, Elisa Giro, and Fernanda Brighenti. A systematic review and meta-analysis of the effect of photodynamic therapy for treatment of oral mucositis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2021. http://dx.doi.org/10.37766/inplasy2021.3.0006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gomer, Charles J. Photodynamic Therapy Oxidative Stress as a Molecular Switch Controlling Therapeutic Gene Expression for the Treatment of Locally Recurrent Breast Carcinoma. Fort Belvoir, VA: Defense Technical Information Center, June 2001. http://dx.doi.org/10.21236/ada396793.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lin, Yao, Junbing He, Liangping Chen, xiaozhu Chen, Shuanglin Liao, Shuai Yang, Yingying Lin, Shuncheng Bai, and Chuhui Huang. A comparative evaluation of lasers and photodynamic therapy in the non-surgical treatment of peri-implant diseases: A Bayesian network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Haitao, Gongwei Long, and Jun Tian. Efficacy and Safety of Photodynamic Therapy for Non–muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0043.

Full text
Abstract:
Review question / Objective: To comprehensively summarize the relevant clinical studies, and assess the efficacy and safety of PDT in the treatment of NMIBC. Eligibility criteria: (1) pathologically confirmed NMIBC; (2) included > 5 patients who received PDT; (3) clinical studies including randomized-controlled trials, case-control studies, and single-arm reports; (4) included efficacy and/or safety results;(5) follow-up duration > 6 months; (6) report was written in English or has a English abstract.
APA, Harvard, Vancouver, ISO, and other styles
8

Li, Yanhui. Efficacy of non-invasive photodynamic therapy for female lower reproductive tract diseases associated with HPV infection: a comprehensive meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, November 2022. http://dx.doi.org/10.37766/inplasy2022.11.0092.

Full text
Abstract:
Review question / Objective: The critical point of this study was to comprehensively evaluate the curative effect of Photodynamic therapy (PDT) in diseases of female lower reproductive tract associated with the human papillomavirus (HPV) infection. Condition being studied: Traditional clinical recommendations for treating diseases of the female lower reproductive tract include topical therapy with drugs, surgery, intravaginal radiation, carbon dioxide (CO2) laser, etc. Although medication is easy to administer, it has a high recurrence rate and adverse effects such as burning sensation, pain, and dyspareunia. The other traditional treatment method is usually invasive, repeated operation of vaginal perforation, scar, easy recurrence, fertility decline, and other shortcomings. At present, the treatment strategy for cervical squamous intraepithelial lesion, vaginal squamous intraepithelial lesion, condyloma acuminatum, and vulvar lichen sclerosis are to protect the normal organ structure and function as much as possible, reduce recurrence, prevent disease progression and carcinogenesis, and preserve female reproductive function.
APA, Harvard, Vancouver, ISO, and other styles
9

Dahm, Philipp, Michelle Brasure, Elizabeth Ester, Eric J. Linskens, Roderick MacDonald, Victoria A. Nelson, Charles Ryan, et al. Therapies for Clinically Localized Prostate Cancer. Agency for Healthcare Research and Quality (AHRQ), September 2020. http://dx.doi.org/10.23970/ahrqepccer230.

Full text
Abstract:
Objective. To update findings from previous Agency for Healthcare Research and Quality (AHRQ)- and American Urological Association (AUA) funded reviews evaluating therapies for clinically localized prostate cancer (CLPC). Sources. Bibliographic databases (2013–January 2020); ClinicalTrials.gov; systematic reviews Methods. Controlled studies of CLPC treatments with duration ≥5 years for mortality and metastases and ≥1 year for quality of life and harms. One investigator rated risk of bias (RoB), extracted data, and assessed certainty of evidence; a second checked accuracy. We analyzed English-language studies with low or medium RoB. We incorporated findings from randomized controlled trials (RCTs) identified in the prior reviews if new RCTs provided information on the same intervention comparison. Results. We identified 67 eligible references; 17 were unique RCTs. Among clinically rather than prostate specific antigen (PSA) detected CLPC, Watchful Waiting (WW) may increase mortality and metastases versus Radical Prostatectomy (RP) at 20+ years. Urinary and erectile dysfunction were lower with WW versus RP. WW’s effect on mortality may vary by tumor risk and age but not by race, health status, comorbidities, or PSA. Active Monitoring (AM) probably results in little to no difference in mortality in PSA detected CLPC versus RP or external beam radiation (EBR) plus Androgen Deprivation (AD) regardless of tumor risk. Metastases were slightly higher with AM. Harms were greater with RP than AM and mixed between EBR plus AD versus AM. 3D-conformal EBR and AD plus low-dose-rate brachytherapy (BT) provided a small reduction in all-cause mortality versus three dimensional conformal EBR and AD but little to no difference on metastases. EBR plus AD versus EBR alone may result in a small reduction in mortality and metastases in higher risk disease but may increase sexual harms. EBR plus neoadjuvant AD versus EBR plus concurrent AD may result in little to no difference in mortality and genitourinary toxicity. Conventionally fractionated EBR versus ultrahypofractionated EBR may result in little to no difference in mortality and metastases and urinary and bowel toxicity. Active Surveillance may result in fewer harms than photodynamic therapy and laparoscopic RP may result in more harms than robotic-assisted RP. Little information exists on other treatments. No studies assessed provider or hospital factors of RP comparative effectiveness. Conclusions. RP reduces mortality versus WW in clinically detected CLPC but causes more harms. Effectiveness may be limited to younger men or to those with intermediate risk disease and requires many years to occur. AM results in little to no mortality difference versus RP or EBR plus AD. EBR plus AD reduces mortality versus EBR alone in higher risk CLPC but may worsen sexual function. Adding low-dose-rate BT to 3D-conformal EBR and AD may reduce mortality in higher risk CLPC. RCTs in PSA-detected and MRI staged CLPC are needed.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography